Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study documentation now shows revision v3.5.4, replacing the prior v3.5.3. This indicates an administrative update to the study materials on the page.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an interface or release version change rather than any new study details.SummaryDifference0.0%

- Check47 days agoChange DetectedAddition: Revision: v3.5.2; Deletion: Revision: v3.5.0. The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.5.0 was applied, updating from v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check112 days agoChange DetectedStudy Documents now lists Revision 3.4.2 for the protocol and related documents, replacing Revision 3.4.1.SummaryDifference0.0%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.